Pneumococcal Serotype Prevalence in Southeast Asia: A Systematic Review and Meta-Analysis
Lister, A. J. J.; Dombay, E.; Cleary, D. W.; Clarke, S. C.
Show abstract
BackgroundThe prevalence of Streptococcus pneumoniae serotypes in the ASEAN region is not well studied despite severe pneumococcal infections being a major cause of death among children in the region. This information is crucial for understanding the epidemiology of the disease and guiding vaccine policies. Our study aimed to provide a thorough analysis of the pneumococcal serotypes in ASEAN prior to vaccine introduction to assist countries in formulating evidence-based vaccine policies. MethodsWe conducted a systematic review and meta-analysis of studies reporting S. pneumoniae serotypes from carriage, invasive disease (IPD) and non-invasive disease (non-IPD) published up until 31st December 2022 using PubMed, PubMed Central, Ovid MEDLINE and Scopus databases, reference lists and search engines. Data prior to the national introduction of conjugate vaccines in the ASEAN region were included. Non-English, animal, case studies, reviews, and studies on antibiotic resistance only were excluded. The quality of studies was examined using the CASP and the JBIs Critical Appraisal Tools. The frequency of serogroups and serotypes was calculated, and vaccine coverage was estimated by the addition of vaccine serotypes as a fraction of the total number of isolates per age group. This study was registered with PROSPERO CRD42022243994. FindingsA total of 940 studies were identified, and 99 and 84 relevant papers were included in the qualitative and quantitative analyses, respectively. A total of 16,396 isolates were identified, spread across all body sites and ages, with vaccine-covered serotypes 19F (n = 2,061, 12.57% [95%CI: 12.07 - 13.09]), 23F (n = 1,508, 9.20% [95%CI: 8.76 - 9.65]) and 6B (n = 1,160, 7.07% [95%CI: 6.69 - 7.48]) occurring most often. Non-vaccine types e.g., 6AB (n = 617, 3.76% [95%CI: 3.48 - 4.07]), 15BC (n = 35, 2.57% [95%CI: 2.33 - 2.82]) and 34 (n = 260, 1.59% [95%CI: 1.40 - 1.79]) were also frequently observed. InterpretationThe most common serotypes found in IPD, non-IPD, and carriage in ASEAN are covered by currently available conjugate vaccines. This underscores the importance of vaccination and predicts future success in reducing the burden of pneumococcal disease. The data gathered offers important insights into pneumococcal serotype epidemiology across the different countries belonging to ASEAN.
Matching journals
The top 6 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- The changing epidemiology of human monkeypox – a potential threat? A systematic review 93%
- A systematic review of the clinical profile of patients with bubonic plague and the outcome measures used in research settings 93%
- Estimation of the morbidity and mortality of congenital Chagas disease: a systematic review and meta-analysis 93%
Similar papers in this journal
- Impact of 10-valent pneumococcal conjugate vaccine on the epidemiology of otitis media with otorrhea among Bangladeshi children 96%
- Effectiveness of ten-valent pneumococcal conjugate vaccine on invasive pneumococcal disease among children <2 years old: a prospective population-based study in rural Bangladesh 96%
- Immunogenicity and Safety of a 14-valent pneumococcal polysaccharide conjugate vaccine (PNEUBEVAX 14TM) administered to 6-8 weeks old healthy Indian Infants: A single blind, randomized, active-controlled, Phase-III study 94%
Similar papers in this journal
- Childhood meningitis in rural Gambia: 10 years of population-based surveillance 94%
- Epidemiology of Respiratory Viruses in Acute Respiratory Illnesses in Malaysia: Patterns, Seasonality and Age Distribution 94%
- Socio-demographic determinants of monkeypox virus preventive behavior: a cross-sectional study in Pakistan 93%
Similar papers in this journal
- Comparison of Monkeypox disease knowledge and perception among the healthcare workers versus the general population during the first month of the WHO emerging infectious disease alert 93%
- Immunogenicity and adverse events of priming with inactivated whole SARS-CoV-2 vaccine (CoronaVac) followed by boosting the ChAdOx1 nCoV-19 vaccine 93%
- Healthcare workers’ worries and Monkeypox vaccine advocacy during the first month of the WHO Monkeypox alert: Cross-sectional survey in Saudi Arabia 93%
Similar papers in this journal
- Improving the last mile delivery of vaccines through an informed push model: experiences, opportunities and costs based on an implementation study in a rural district in Uganda 93%
- The immediate treatment outcomes and cost estimate for managing clinical measles in children admitted at Mulago Hospital: a retrospective cohort study 92%
- Epidemiological and virological factors determining dengue transmission in Sri Lanka during the COVID-19 pandemic 92%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.